isocarboxazid has been researched along with Myoclonic Jerk in 3 studies
Isocarboxazid: An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)
Excerpt | Relevance | Reference |
---|---|---|
"The neurochemical basis of myoclonus responding to 5HT precursors and clonazepam is discussed." | 1.26 | Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam. ( Chadwick, D; Hallett, M; Harris, R; Jenner, P; Marsden, CD; Reynolds, EH, 1977) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Riehl, JL | 1 |
Lee, DK | 1 |
Andrews, JM | 1 |
Brown, WJ | 1 |
Chadwick, D | 2 |
Hallett, M | 2 |
Harris, R | 1 |
Jenner, P | 2 |
Reynolds, EH | 1 |
Marsden, CD | 2 |
3 other studies available for isocarboxazid and Myoclonic Jerk
Article | Year |
---|---|
Electrophysiological and neuropharmacological studies in a patient with Unverricht-Lafora's disease.
Topics: Amphetamine; Atropine; Child; Chlordiazepoxide; Cytoplasmic Granules; Diphenhydramine; Electroenceph | 1967 |
Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Aged; Benzodiazepinones; Carbidopa; Child, Preschool; Clonaz | 1977 |
Treatment of posthypoxic action myoclonus: implications for the pathophysiology of the disorder.
Topics: 5-Hydroxytryptophan; Benzodiazepines; Clonazepam; Female; Fenclonine; Humans; Hydroxyindoleacetic Ac | 1986 |